Sinovac Biotech Ltd. - stock earnings
Stock symbol SVA is outdated, potentially delisted? Maybe it is available on other exchange?
SVA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020Q4 | 108.8 million USD | 327.5 million USD |
| 2020Q3 | 11.2 million USD | 115.5 million USD |
| 2020Q2 | -3.8 million USD | 52.3 million USD |
| 2020Q1 | -5.9 million USD | 15.4 million USD |
SVA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | 110.4 million USD | 510.6 million USD |
| 2019 | 44.9 million USD | 246.1 million USD |
| 2018 | 21.8 million USD | 229.7 million USD |
| 2017 | 25.8 million USD | 174.3 million USD |
SVA
Price: $6.47
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: 6.66
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 8227
Ebitda: -837000Market Capitalization: 642.4 million